Nomura Real Estate Master Stock (OTC: NMMRF)

Nomura Real Estate Master (OTC:NMMRF) Stock, Quote.Headers.trade-ideas

Nomura Real Estate Master Fund Inc is a Japanese based company operates as a real estate investment trust. It is implementing medium- to long-term management Strategy, to achieve securing stable income over the medium to long term period, also ensures the steady growth of assets under management. The company invests in logistic facilities and commercial facilities in the Tokyo metropolitan area. It is managed by the fund manager Nomura Real Estate Asset Management Co Ltd.

NOMURA REAL ESTATE MAS FD by Nomura Real Estate Master Fd Inc.

Nomura Real Estate Master Fund Inc

Macro Economic Events

News

Econ #s

Economics

France Harmonised Index of Consumer Prices (MoM) For November 0.3% Vs. -0.1% Est.; 0.3% Prior

France Consumer Price Index (MoM) For November -0.1% Vs. 0.1% Est.; 0.3% Prior

ACOG

Reported Earlier, Alpha Cognition To Voluntarily Delist From Canadian Securities Exchange On December 17, 2024

US$10 million milestone payment to HUTCHMED follows first national reimbursement in Europe&nbsp;—
— Follows June 2024 European approval of FRUZAQLA&#xAE; (fruquintinib), the first novel oral targeted therapy in the EU for metastatic colorectal cancer regardless of biomarker status in over a decade&nbsp;—

Reported Earlier, HUTCHMED to Receive $10M Payment From Takeda As FRUZAQLA Achieves First National Reimbursement In Europe For Metastatic Colorectal Cance

SYH2039 targets solid tumors that have a mutation called MTAP deletion, which is estimated to be present in approximately 15 percent of all cancer types with the most common including glioblastoma, pancreatic cancer and non-small cell lung cancer.
"With one of the most dynamic solid tumor portfolios in the industry, we are continually assessing opportunities that align with our strategic focus and address significant unmet needs for patients. This MAT2A inhibitor is a valuable addition to our solid tumor pipeline, and we're eager to explore its potential, particularly in combination with our internally developed PRMT5 inhibitor, BGB-58067. Together, these assets hold promise for advancing treatment across a range of solid tumors," said Lai Wang, Ph.D., Global Head of R&amp;D at BeiGene.

BGNE

Reported Earlier, BeiGene Secures Global Licensing Agreement For Novel MAT2A Inhibitor SYH2039 To Target MTAP-Deleted Solid Tumors

Investigation Details: The Company has uncovered evidence suggesting that Yi Zhang, during his tenure in key executive roles, misappropriated corporate assets for personal gain and mismanaged the Company, resulting in significant financial losses over past several years, thereby seriously harming the interests of shareholders of the Company.
Corrective Actions: In response to these revelations, by March 2024, the Company took decisive action to remove Yi Zhang from all executive positions within the Company and its subsidiaries, in accordance with the Company's Memorandum and Articles of Association effective at that time and relevant laws. This action was necessary to mitigate the damage caused by Yi Zhang and his associates. Under the new leadership, the Company's financial and operational performance has seen a marked improvement. The Company has achieved smooth operations, secured second position in China's Rabies vaccine market and reaffirmed the full year financial guidance through Fiscal Year 2025 ended March 31, 2025.

Reported Earlier, LakeShore Biopharma Takes Decisive Action In Response To Criminal Allegations Against Former Chairman, Yi Zhang

Germany Trade Balance For October 13.4B Vs. 15.7B Est.; 17.0B Prior

U.K. Trade Balance Non-EU For October -7.28B Vs. -5.31B Prior

U.K. Trade Balance For October -18.97B Vs. -16.10B Est.; -16.32B Prior

U.K. Monthly Gross Domestic Product (GDP) 3M/3M Change For October 0.1% Vs. 0.2% Est.; 0.1% Prior

U.K. Manufacturing Production (MoM) For October -0.6% Vs. 0.2% Est.; -1.0% Prior

U.K. Industrial Production (MoM) For October -0.6% Vs. 0.3% Est.; -0.5% Prior

U.K. Gross Domestic Product (MoM) For October -0.1% Vs. 0.1% Est.; -0.1% Prior

With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) posted downbeat earnings and sales results for its third quarter. However, the company raised revenue guidance across the board based on current trends. The company expects fourth-quarter demand growth of 20% to 22%, and fourth-quarter revenue growth of 18% to 20%, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. RH shares jumped 17.7% to $448.70 in the after-hours trading session.</li>
<li>Wall Street expects 51Talk Online Education Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COE#NYSE">COE</a>) to report its unaudited financial results for the third quarter ended Sept. 30, before the opening bell. 51Talk Online Education shares fell 2.9% to $17.00 in after-hours trading.</li>
<li>Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) posted better-than-expected earnings for its fourth quarter. The company said it sees first-quarter revenue of approximately $14.6 billion, versus the $14.612 billion estimate. The company also issued adjusted EBITDA guidance of approximately 66 percent of projected revenue for the first quarter. Broadcom shares jumped 14.1% to $206.10 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Inovio Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) announced a proposed public offering. Inovio Pharmaceuticals shares dipped 21% to $2.9696 in the after-hours trading session.</li>
<li>Costco Wholesale Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) reported upbeat results for its first quarter on Thursday. The company reported first-quarter revenue of $62.15 billion, beating the consensus estimate of $62.08 billion. Costco shares fell 0.6% to close at $988.39 on Thursday.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42460676/jim-cramer-amd-ceo-lisa-su-built-an-amazing-company">Jim Cramer Says This CEO &#8216;Built An Amazing Company,&#8217; Recommends Buying Netflix</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Pre-Market Outlook

Markets

Trading Ideas

AVGO

COST

RH, Broadcom And 3 Stocks To Watch Heading Into Friday

MYNZ

Reported Earlier, Mainz Biomed Prices $8M Follow-On Offering Of 1,367,521 Units At $5.85/Unit Under Nasdaq Rules

Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) subsidiary Google&#8217;s video streaming platform YouTube is pushing forward with a significant price increase, raising its base TV subscription plan from $72.99 to $82.99 per month, effective immediately for new customers and Jan. 13, 2025, for existing subscribers.
What Happened: The streaming service attributes the 14% price hike to the &#8220;rising cost of content,&#8221; marking another substantial increase in its pricing strategy. Since March 2018, YouTube TV has more than doubled its monthly rate, escalating from $40 to $83 in just under six years.
&#8220;We don&#8217;t make these decisions lightly,&#8221; the YouTube TV team acknowledged in a statement on X, emphasizing their commitment to delivering comprehensive entertainment options. The service offers more than 100 channels, unlimited cloud DVR storage, up to six account profiles, and three simultaneous streaming capabilities.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">A message for our members: we have always worked to offer the content you love, with features to enjoy the best of live TV. To keep up with rising content costs, we're updating our monthly price to $82.99/mo. (1/3)
&mdash; YouTube TV (@YouTubeTV) <a href="https://twitter.com/YouTubeTV/status/1867236661173612567?ref_src=twsrc%5Etfw">December 12, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/24/12/42476730/peter-thiels-founders-fund-leads-600m-crusoe-investment-betting-big-on-ai-infrastructure">Peter Thiel Says, &#8216;The Biggest Risk With AI Is That We Don&#8217;t Go Big Enough&#8217; As His Founders Fund Leads $600 Million Crusoe Investment</a>
Why It Matters: This latest price adjustment follows the service&#8217;s March 2023 increase from $64.99 to $72.99, signaling a trend of continuous value reassessment in the competitive streaming market. 
The move comes as streaming platforms like Netflix Inc. and YouTube navigate complex <a href="https://www.benzinga.com/general/entertainment/24/07/39853498/netflix-aims-to-capture-broader-tv-market-sees-youtube-as-both-competitor-and-partner-we-ki">content acquisition and pricing landscapes</a>.
YouTube dominated election day livestream coverage in the 2024 U.S. presidential election, capturing over 80% of total watch time across platforms. Streams Charts reported nearly 84 million hours of election-related watch time, significantly surpassing the <a href="https://www.benzinga.com/news/24/11/41799868/youtube-trumps-rivals-in-election-day-coverage-with-80-viewership-share-in-streaming">September debates' viewership</a>.
The video platform&nbsp;Google&nbsp;acquired for $1.65 billion in 2006, has generated $50 billion in combined advertising and subscription revenue over the past four quarters, marking a milestone in its evolution from a user-generated content site to a&nbsp;<a href="https://www.benzinga.com/general/entertainment/24/10/41616337/google-bought-youtube-for-1-65b-and-now-it-prints-50b-in-revenue-just-in-1-year-sundar-pich">major streaming player.</a>
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42477035/dan-ives-predicts-apple-to-ship-record-240-million-iphones-in-2025-sparking-multi-year-supercycle-as-ai-integration-drives-growth">Dan Ives Predicts Apple To Ship Record 240 Million iPhones In 2025, Sparking &#8216;Multi-Year Supercycle&#8217; As AI Integration Drives Growth</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors
Photo courtesy: Shutterstock

Entertainment

Equities

Tech

GOOG

GOOGL

YouTube Raises TV Subscription Rates By 14% To $83 Per Month, Citing Rising Content Costs: Prices Have More Than Doubled In Less Than 6 Years

LAES

Reported Earlier, SEALSQ Announces Pricing Of $10M Registered Direct Offering: 7.69M Shares At $1.30 Per Share

CG Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer, today announced the pricing of its public offering of 8,000,000 shares of its common stock, 7,300,000 of which are being offered by CG Oncology and 700,000 of which are being offered by an existing stockholder of CG Oncology, each at a public offering price of&nbsp;$28.00&nbsp;per share. The gross proceeds to CG Oncology from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $204.4 million

CGON

Reported Earlier, CG Oncology Prices $204.4M Public Offering Of 8M Common Shares At $28/Share

The units are expected to be listed on The Nasdaq Stock Market LLC ("Nasdaq") and begin trading tomorrow, December 13, 2024, under the ticker symbol "MLACU." Each unit consists of one Class A ordinary share and one right. Each right entitles the holder thereof to receive one-tenth (1/10) of one Class A ordinary share upon the consummation of an initial business combination.&nbsp;

IPOs

MLAC

MLACU

Reported Earlier, Mountain Lake Acquisition Prices Upsized $210M Initial Public Offering Of 21M Units At $10/Unit

UNIT

Reported Earlier, Uniti Group Announces $1.4B Pricing For Windstream's Add-On Offering Of 8.250% Senior First Lien Notes Due 2031

Nomura Real Estate Master (JP:3462) has released an update. Nomura Real Estate Master Fund, Inc. has established a Commitment Line Agreement with m...

Nomura Master Fund Secures 40 Billion Yen Credit Line

Nomura Real Estate Master (JP:3462) has released an update. Nomura Real Estate Master Fund, Inc. has announced upcoming changes in its director and...

Nomura Master Fund Announces Leadership Changes

Nomura Real Estate Master (JP:3462) has released an update. Nomura Real Estate Master Fund, Inc. has announced the procurement of a hotel property ...

Nomura Real Estate Fund Expands Portfolio with Hotel Acquisition

Nomura Real Estate Master (JP:3462) has released an update. Nomura Real Estate Master Fund, Inc. has resolved to issue unsecured investment corpora...

Nomura Real Estate Announces Multi-Billion Yen Bond Issue

Nomura Real Estate Master (JP:3462) has released an update. Nomura Real Estate Master Fund, Inc. plans to secure 4,520 million yen in debt financin...

Nomura Real Estate Secures Funding for Asset Acquisition

Nomura Real Estate Master (JP:3462) has released an update. Nomura Real Estate Master Fund, Inc. has decided to sell the NMF Shinjuku Minamiguchi B...

Nomura Real Estate Fund Sells Prime Shinjuku Asset

Nomura Real Estate Master (JP:3462) has released an update. Nomura Real Estate Master Fund has announced a plan to purchase and subsequently cancel...

Nomura Real Estate Fund to Buy Back Units

Nomura Real Estate Master (JP:3462) has released an update. Nomura Real Estate Master Fund, Inc. is set to secure debt financing to redeem its firs...

Nomura Real Estate Master Fund Plans Debt Refinancing

Nomura Real Estate Master (JP:3462) has released an update. Nomura Real Estate Master Fund has announced the interest rate for its recently determi...

Comments

Nomura Real Estate Master

Nomura Real Estate Master (NMMRF) Forecast

Nomura Real Estate Master (OTC:NMMRF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga